West Pharmaceutical Services Inc. Stock Rises 4.8%, Outperforms Competitors

Dow Jones
25 Feb

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. rose 4.8% to $221.07 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the S&P 500 Index falling 0.5% to 5,983.25.

This was the stock's third consecutive day of gains.

West Pharmaceutical Services Inc. closed 44.9% below its 52-week high of $400.88, which the company reached on March 21st.

The stock outperformed some of its competitors, as Abbott Laboratories remained unchanged, Becton Dickinson & Co. rose 1.3% to $230.31, and Baxter International Inc. rose 3.73% to $35.08.

Trading volume totaled 1.5 million, compared to the 50-day average of 807,651.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 24, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10